BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

480 related articles for article (PubMed ID: 36055231)

  • 1. Clinical application of advanced multi-omics tumor profiling: Shaping precision oncology of the future.
    Akhoundova D; Rubin MA
    Cancer Cell; 2022 Sep; 40(9):920-938. PubMed ID: 36055231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Need for Multi-Omics Biomarker Signatures in Precision Medicine.
    Olivier M; Asmis R; Hawkins GA; Howard TD; Cox LA
    Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31561483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel omics technology driving translational research in precision oncology.
    Basu A; Budhraja A; Juwayria ; Abhilash D; Gupta I
    Adv Genet; 2021; 108():81-145. PubMed ID: 34844717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Detailed Catalogue of Multi-Omics Methodologies for Identification of Putative Biomarkers and Causal Molecular Networks in Translational Cancer Research.
    Vlachavas EI; Bohn J; Ückert F; Nürnberg S
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33802234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Precision Oncology Beyond Genomics: The Future Is Here-It Is Just Not Evenly Distributed.
    Pfohl U; Pflaume A; Regenbrecht M; Finkler S; Graf Adelmann Q; Reinhard C; Regenbrecht CRA; Wedeken L
    Cells; 2021 Apr; 10(4):. PubMed ID: 33920536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comprehensive review of machine learning techniques for multi-omics data integration: challenges and applications in precision oncology.
    Acharya D; Mukhopadhyay A
    Brief Funct Genomics; 2024 Apr; ():. PubMed ID: 38600757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single-cell multi-omics sequencing and its application in tumor heterogeneity.
    Sun Y; Liu Z; Fu Y; Yang Y; Lu J; Pan M; Wen T; Xie X; Bai Y; Ge Q
    Brief Funct Genomics; 2023 Jul; 22(4):313-328. PubMed ID: 37078714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Precision medicine in colorectal cancer: Leveraging multi-omics, spatial omics, and artificial intelligence.
    Xu Z; Li W; Dong X; Chen Y; Zhang D; Wang J; Zhou L; He G
    Clin Chim Acta; 2024 Jun; 559():119686. PubMed ID: 38663471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Omics-Based Strategies in Precision Medicine: Toward a Paradigm Shift in Inborn Errors of Metabolism Investigations.
    Tebani A; Afonso C; Marret S; Bekri S
    Int J Mol Sci; 2016 Sep; 17(9):. PubMed ID: 27649151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integration of pan-omics technologies and three-dimensional in vitro tumor models: an approach toward drug discovery and precision medicine.
    Jose A; Kulkarni P; Thilakan J; Munisamy M; Malhotra AG; Singh J; Kumar A; Rangnekar VM; Arya N; Rao M
    Mol Cancer; 2024 Mar; 23(1):50. PubMed ID: 38461268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient-specific multi-omics models and the application in personalized combination therapy.
    John A; Qin B; Kalari KR; Wang L; Yu J
    Future Oncol; 2020 Aug; 16(23):1737-1750. PubMed ID: 32462937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The translational challenges of precision oncology.
    Pich O; Bailey C; Watkins TBK; Zaccaria S; Jamal-Hanjani M; Swanton C
    Cancer Cell; 2022 May; 40(5):458-478. PubMed ID: 35487215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcriptomics and solid tumors: The next frontier in precision cancer medicine.
    Tsimberidou AM; Fountzilas E; Bleris L; Kurzrock R
    Semin Cancer Biol; 2022 Sep; 84():50-59. PubMed ID: 32950605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single-Cell Sequencing Technologies in Precision Oncology.
    Melnekoff DT; Laganà A
    Adv Exp Med Biol; 2022; 1361():269-282. PubMed ID: 35230694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer biomarker discovery and translation: proteomics and beyond.
    Hristova VA; Chan DW
    Expert Rev Proteomics; 2019 Feb; 16(2):93-103. PubMed ID: 30556752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multi-omics analysis: Paving the path toward achieving precision medicine in cancer treatment and immuno-oncology.
    Raufaste-Cazavieille V; Santiago R; Droit A
    Front Mol Biosci; 2022; 9():962743. PubMed ID: 36304921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Omics sciences and precision medicine in Urothelial Carcinoma.
    Medori MC; Micheletti C; Madeo G; Maltese PE; Tanzi B; Tezzele S; Mareso C; Generali D; Donofrio CA; Donofrio CA; Cominetti M; Fioravanti A; Riccio L; Beccari T; Ceccarini MR; Stuppia L; Stuppia L; Gatta V; Cristoni S; Ahmed R; Ahmed R; Cecchin S; Marceddu G; Bertelli M
    Clin Ter; 2023; 174(Suppl 2(6)):1-10. PubMed ID: 37994743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genomic profiling in oncology clinical practice.
    Rodríguez N; Viñal D; Rodríguez-Cobos J; De Castro J; Domínguez G
    Clin Transl Oncol; 2020 Sep; 22(9):1430-1439. PubMed ID: 31981077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Onco-proteogenomics: Multi-omics level data integration for accurate phenotype prediction.
    Dimitrakopoulos L; Prassas I; Diamandis EP; Charames GS
    Crit Rev Clin Lab Sci; 2017 Sep; 54(6):414-432. PubMed ID: 29025326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Omics sciences and precision medicine in glioblastoma.
    Micheletti C; Bonetti G; Madeo G; Gadler M; Benedetti S; Guerri G; Cristofoli F; Generali D; Donofrio CA; Cominetti M; Fioravanti A; Riccio L; Manganotti P; Caruso P; Bernini A; Fulcheri E; Stuppia L; Gatta V; Cecchin S; Marceddu G; Bertelli M
    Clin Ter; 2023; 174(Suppl 2(6)):77-84. PubMed ID: 37994751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.